Securities & Capital Markets
Viewpoints
Filter by:
Not So Fast: DOL Changes Course on Trump-Era ESG Investment Rule
March 22, 2021 | Blog | By Alyssa C. Scruggs
The United States Department of Labor’s (“DOL”) Employee Benefits Security Administration (“EBSA”) announced on March 10, 2021 that it will not enforce certain final rules put into place under President Trump related to environmental, social, and governance (“ESG”) investing.
Read more
The OASB Annual Report to Congress for Fiscal Year 2020
March 15, 2021 | Blog | By Amanda Mei
In January 2019, the Office of the Advocate for Small Business Capital Formation (the “Office”) was formed “to advance the interests of small businesses and their investors at the SEC and in the capital markets.” These small businesses include early-stage start-ups, small public companies, and everything in between. Each year, the Office prepares an annual report to Congress, which among other things, explains issues that small businesses face with respect to raising capital, including a focus on minority- and women-owned businesses. Included are some of the highlights from this year’s annual report, including a few of the Office’s recommendations to Congress.
Read more
SPAC Chat: Busting Common Myths about SPACs
February 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
Special Purpose Acquisition Companies (SPACs) are taking over Wall Street as more and more companies are taking advantage of this alternative IPO strategy.
Read more
SEC Amends MD&A and Other Financial Disclosure Rules
February 5, 2021 | Alert | By Daniel T. Kajunski, Amanda Mei
This advisory summarizes SEC amendments, effective February 10, 202, to MD&A and other financial disclosure requirements and provides a chart highlighting the amended rules.
Read more
Preparation for 2020 Fiscal Year-End SEC Filings and 2021 Annual Shareholder Meetings
January 21, 2021 | Advisory | By Megan Gates, John Condon, Daniel T. Kajunski, Anne Bruno
Read about regulatory and other developments public companies need to consider as they prepare for fiscal year-end Securities and Exchange Commission filings and 2021 annual shareholder meetings.
Read more
How Companies Can Prepare for SEC Proxy Advisor Reform
January 12, 2021 | Advisory | By Anne Bruno
This advisory discusses the SEC’s final rules — effective November 2, 2020 — governing voting advice provided by proxy advisory firms such as Institutional Shareholders Service (ISS) and Glass Lewis.
Read more
SEC Adopts Rules to Allow the Use of Electronic Signatures
November 19, 2020 | Alert | By Daniel T. Kajunski
This alert discusses the SEC’s November 17, 2020 adoption of rule amendments that allow the use of electronic signatures in some circumstances — a step that will streamline filing procedures for public companies.
Read more
SEC Harmonizes and Improves “Patchwork” Private Offering Framework
November 12, 2020 | Alert
Read about the SEC’s November 2 adoption of amendments designed to harmonize and simplify the complex framework of private offering exemptions.
Read more
SEC Proposes Relief from Broker-Dealer Registration for Certain Finders
October 13, 2020 | Alert | By Steve Ganis
Read about an SEC proposal to exempt certain individuals seeking to find investors for private companies and unregistered funds from federal broker-dealer regulation requirements.
Read more
SEC Amends Shareholder Proposal Eligibility Rules
October 5, 2020 | Advisory | By Daniel T. Kajunski, Zachary Liebnick
Read about the SEC’s final amendments to the shareholder-proposal requirements of Rule 14a-8 under the Securities Exchange Act of 1934, as amended.
Read more
NYSE Further Extends Waiver of Certain Shareholder Approval Requirements as a Result of Coronavirus (COVID-19)
October 2, 2020 | Advisory | By Daniel T. Kajunski
Read about NYSE’s extension of the waiver of certain shareholder approval requirements as a result of the coronavirus through December 31, 2020.
Read more
SEC Expands “Accredited Investor” and “Qualified Institutional Buyer” Definitions
August 31, 2020 | Advisory | By Daniel T. Kajunski
This advisory discusses the SEC's final rule that adopts changes to the definitions of “accredited investor” and “qualified institutional buyer.”
Read more
Is it Time to Appoint a New Director? Five Corporate Governance Considerations for Board Members
August 17, 2020 | Blog
Regardless of size or industry, thoughtful director appointment is critical to the success of any public company. Yet following the departure of a director, many boards are left scrambling to locate and onboard a suitable replacement. Even boards that purposely undertake to increase the number of directors may struggle to balance numerous (and sometimes competing) concerns. Below are a few pointers for promoting good corporate governance practices when appointing a new director.
Read more
Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources
July 21, 2020 | Advisory | By Anne Bruno
This advisory discusses the SEC’s recent guidance on operations, liquidity, and capital resources disclosure that companies should consider in light of the COVID-19 pandemic.
Read more
Strategies for Adjusting Executive Performance Goals in the Covid-19 Era
July 20, 2020 | Advisory | By Anne Bruno
This advisory summarizes recent proxy advisor guidance on and strategies for adjusting annual performance goals in light of the COVID-19 pandemic.
Read more
NYSE Extends Waiver of Certain Shareholder Approval Requirements as a Result of Coronavirus (COVID-19)
July 7, 2020 | Advisory | By Daniel T. Kajunski
This advisory discusses the SEC’s approval of an NYSE waiver extension that gives NYSE-listed companies through September 30, 2020 to complete certain capital raising transactions.
Read more
SEC Extends Email Delivery of Certain Paper Documents as a Result of Coronavirus (COVID-19)
July 1, 2020 | Advisory | By Daniel T. Kajunski
Read about the SEC’s extension of email delivery of certain paper documents, including certain reports by foreign private issuers, as a result of the coronavirus.
Read more
SEC Extends Guidance on Manual Signatures Required under Rule 302(b) of Regulation S-T as a Result of Coronavirus (COVID-19)
July 1, 2020 | Advisory | By Daniel T. Kajunski
Read about the SEC’s extension of its earlier guidance on manual signatures required under Rule 302(b) of Regulation S-T as a result of the coronavirus.
Read more
SEC Adopts Amendments to Financial Disclosure Requirements for Business Acquisitions and Dispositions
June 25, 2020 | Advisory | By Daniel A. Lerner
This advisory discusses SEC’s amendments to the financial disclosure requirements for business acquisitions and dispositions by reporting companies and IPO candidates.
Read more
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology